ReviewTopics in current chemistry (Cham)2026
Earth-Abundant Transition Metals Catalyzed Alkylation, Alkenylation, and Alkynylation of Arenes via Cross Dehydrogenative Coupling (CDC): Synthetic Strategies and Mechanistic Pathways.
Review in Topics in current chemistry (Cham), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cross dehydrogenative coupling (CDC) via C-H bond activation enables direct and sustainable synthesis of carbon-carbon and carbon-heteroatom bonds, bypassing the requirement of prefunctionalization steps. Utilizing earth-abundant metals such as iron (Fe), cobalt (Co), nickel (Ni), and copper (Cu), CDC offers cost-effective, environmentally friendly alternatives to precious metal catalysts (Ru, Rh, Pd, Ir). These metals facilitate mild and efficient C-H activation, expanding substrate scope and improving selectivity. Among different methods, transition metal-catalyzed C-H activation via CDC has emerged as an effective tool for direct functionalization, offering efficiency, sustainability, and regioselectivity. Recent advancements address challenges such as catalyst deactivation and functional group compatibility. This article highlights recent developments of various synthetic alkylation, alkenylation, and alkynylation strategies of arenes and their mechanistic pathways catalyzed by earth-abundant metals (Fe, Co, Ni, and Cu) through cross dehydrogenative coupling via C-H bond activation.
Indexed as
Identifiers
41787042What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.